CYH · Community Health Systems Inc
$3.00
+0.03 (+1.01%)
At close · Aug 14
Market Cap
$423.03M
Shares
141.01M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Tim L. Hingtgen | Former Chief Executive Officer | $7,854,699 |
| Kevin J. Hammons | Chief Executive Officer | $4,772,869 |
| Kevin Stockton | Executive Vice President Operations and Development | $2,793,696 |
| Mark B. Medley | Regional President | $2,476,228 |
| Chad A. Campbell | Regional President | $2,418,534 |
| Jason K. Johnson | Executive Vice President and Chief Financial Officer | $1,406,434 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Tim L. Hingtgen | Chief Executive Officer | $7,629,625 |
| Kevin J. Hammons | President and Chief Financial Officer | $3,473,366 |
| Kevin Stockton | Executive Vice President Operations and Development | $2,167,494 |
| Lynn T. Simon | President, Healthcare Innovation and Chief Medical Officer | $2,099,527 |
| Chad A. Campbell | Regional President | $1,925,480 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Tim L. Hingtgen | Chief Executive Officer | $8,348,223 |
| Kevin J. Hammons | President and Chief Financial Officer | $3,750,006 |
| Lynn T. Simon | President, Healthcare Innovation and Chief Medical Officer | $2,144,471 |
| Chad A. Campbell | Regional President | $1,657,282 |
| Kevin Stockton | Executive Vice President Operations and Development | $1,602,702 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Tim L. Hingtgen | Chief Executive Officer | $6,302,542 |
| Kevin J. Hammons | President and Chief Financial Officer | $4,191,086 |
| Lynn T. Simon | President, Healthcare Innovation and Chief Medical Officer | $2,651,388 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Phillip A. Posey | Senior Vice President and Chief Accounting Officer | Appointed | 2025-12-10 |
| Jason K. Johnson | Executive Vice President and Chief Financial Officer | Appointed | 2025-12-10 |
| Kevin J. Hammons | member of the Company's Board | Appointed | 2025-12-10 |
| Kevin J. Hammons | Chief Executive Officer | Appointed | 2025-12-10 |
| Tim L. Hingtgen | Chief Executive Officer | Retired | 2025-09-30 |
| Jason K. Johnson | Interim Chief Financial Officer | Appointed | 2025-09-10 |
| Tim L. Hingtgen | Chief Executive Officer | Retired | 2025-09-10 |
| Kevin J. Hammons | Interim Chief Executive Officer | Appointed | 2025-09-10 |
| Jason K. Johnson | Interim Chief Financial Officer | Appointed | 2025-07-23 |
| Kevin J. Hammons | Interim Chief Executive Officer | Appointed | 2025-07-23 |
| Tim L. Hingtgen | member of the Board of Directors | Retired | 2025-07-23 |
| Tim L. Hingtgen | Chief Executive Officer | Retired | 2025-07-23 |
| Lynn T. Simon, M.D. | President, Healthcare Innovation and Chief Medical Officer | Retired | 2024-12-31 |
| Miguel S. Benet | President of Clinical Operations and Chief Medical Officer | Appointed | 2024-09-11 |
| Ronald L. Burgess Jr. | Board of Directors | Appointed | 2023-09-13 |
| Lt. Gen. Ronald L. Burgess, Jr. | director | Appointed | 2023-09-13 |
| H. James Williams, Ph.D. | director | Appointed | 2023-05-10 |
| Wayne T. Smith | director | Appointed | 2023-05-10 |
| K. Ranga Krishnan, MBBS | director | Appointed | 2023-05-10 |
| Elizabeth T. Hirsch | director | Appointed | 2023-05-10 |
| William Norris Jennings, M.D. | director | Appointed | 2023-05-10 |
| Tim L. Hingtgen | director | Appointed | 2023-05-10 |
| Joseph A. Hastings, D.M.D. | director | Appointed | 2023-05-10 |
| James S. Ely III | director | Appointed | 2023-05-10 |
| John A. Fry | director | Appointed | 2023-05-10 |
Key facts
CIK
1108109
CUSIP
203668108
13F (30d)
172 filings
167 filers
Visit website
Investor relations